Table 1

Outcome measures and time-points for collection

MeasureParticipantParticipating supporter
Eligibility and consent visitBaseline
due <2 months prior to the intervention start date
8 months
due <2 weeks before and <8 weeks after the 8 month anniversary of randomisation
12 months
due <2 weeks before and <8 weeks after the 12 month anniversary of randomisation, if within study timelines
Baseline
same timings as participant baseline visit
8 months
same timings as participant 8 month visit
Capacity assessment
Mini Mental State Examination
Eligibility checklist
Baseline demographics
DEMQOL ✓*
EQ-5D-5L
PHQ-9
GAD-7
GSE
DFS
SMAS
IADL
HSCRU
SCQ
  • *Denotes the primary outcome measure.

  • DEMQOL, Dementia-Related Quality of Life; DFS, Diener’s Flourishing Scale; EQ-5D-5L, European Quality of Life-5 Dimensions, 5 level version; GAD-7, Generalised Anxiety Disorder-7; GSE, General Self-Efficacy Scale; HSCRU, Health and Social Care Resource Use Questionnaire; IADL, Instrumental Activities of Daily Living; PHQ-9, Patient Health Questionnaire-9; SCQ, Sense of Competency Questionnaire; SMAS, Self-Management Ability Scale.